Skip to main content
Equibles
SLGN logo

SLGN · Silgan Holdings Inc

Track SLGN — free

Use SLGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SLGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$40.82 -0.82 (-1.97%)
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$4.36B
Shares
105.68M
Volume · Nov 6 136.15K Avg daily vol (3M) 1.14M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$41.64 Open$42.93 Day$40.90–43.34 52W close$34.75–48.89 Avg vol 30d1.2M Short int9.3M · 8.8% of shares · 8.6d Short vol45% Last earningsOct 29, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 5

Up next

Next earnings call
Jan 29, 2027 Est · unconfirmed · in 12 wks
Q3 2026 earnings call transcript
call held Oct 29, 2026
Play latest call

Latest documents

2026
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Sales rise as profit margin declines

Third-quarter net sales rose 1.6 percent to $2.0 billion, but income before interest and income taxes fell to $191.7 million and margin declined to 9.4 percent from 9.9 percent. Total adjusted EBIT increased to $235.0 million from $221.4 million.

Revenue $2.04B ▲ 1.6% Net income $104.98M ▼ 7.3% Diluted EPS $0.99 ▼ 6.6%
Read from the MD&A section
3 source passages
In the third quarter of 2026, consolidated net sales were $2.0 billion, an increase of $31.5 million, or 1.6 percent, as compared to the third quarter of 2025 primarily due to the pass through of higher raw material and other manufacturing costs and a more favorable mix of products sold in the custom containers segment, partially offset by a less favorable mix of products sold in the dispensing and specialty closures segment, lower volumes in the metal containers and custom containers segments and the impact from unfavorable foreign currency translation of approximately $5.0 million. In the third quarter of 2026, income before interest and income taxes decreased by $7.0 million to $191.7 million as compared to $198.7 million in the third quarter of 2025, and margins decreased to 9.4 percent from 9.9 percent over the same periods. Total adjusted EBIT | 235.0 | 221.4 | 572.2 | 572.6 Open the document at this passage
Nov 3
Current report 8-K
Other events AI summary on its way
Oct 29
Earnings call
Q3 2026 earnings call

Silgan Holdings Inc. reported third-quarter 2026 adjusted EPS of $1.31, up 7%. It raised 2026 adjusted EPS guidance to $3.83 to $3.93, maintained free cash flow of approximately $450 million, and expects the proposed Trivium acquisition to close mid-2027.

Oct 29
Current report 8-K
Financial results

Silgan Holdings Inc. reported third quarter 2026 net sales of $2.04 billion and adjusted diluted EPS of $1.31, raised its full year 2026 adjusted diluted EPS range to $3.83 to $3.93, and confirmed free cash flow of approximately $450 million.

Oct 20
Current report 8-K Events of Oct 17
Entered into a material agreement, Director or officer change, or executive pay

Silgan Holdings Inc. will contribute its Metal Containers and Closures Business to MetalCo for 60% of MetalCo’s Class A voting units; A-VL Investor will contribute $1.025 billion for 40%, and MetalCo proposes to acquire Trivium.

Read from the first part of this long document
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$6.71B
Trailing 12 months
Net income (TTM)
$261.98M
Trailing 12 months
Revenue growth YoY
+1.6%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
17.1
Trailing earnings · reciprocal yield 5.8%
FCF yield
8.0%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$4.22B
Latest balance sheet
Dividend yield
1.9%
Trailing 12 months
Shares change YoY
-0.8%
Year over year · fewer shares
Price change (1Y)
+10.5%
Trailing year
Short interest
8.8%
Latest settlement · 8.6 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▲5.3% $1.41B $45.06M '24 Q4* ▲11.4% $1.47B $67.96M '25 Q1 ▲11.4% $1.54B $88.94M '25 Q2 ▲15.1% $2.01B $113.29M '25 Q3 ▲4.1% $1.47B $18.20M '25 Q4* ▲6.4% $1.56B $63.04M '26 Q1 ▲6.8% $1.64B $75.76M '26 Q2 LATEST ▲1.6% $2.04B $104.98M '26 Q3

* Q4 derived as the full year minus Q1 to Q3.

AI Brief

Q3 FY26 earnings call · Oct 29, 2026
Q3 FY26

TL;DR. Silgan raised full-year 2026 adjusted EPS guidance to $3.83-$3.93, delivered record third-quarter adjusted EPS of $1.31, up 7%, and guides fourth-quarter adjusted EPS to $0.76-$0.86, while metal-container adjusted EBIT rose 10%. Fragrance and prescription pharma dispensing grew and management expects organic earnings and free cash flow growth in 2027, but muted consumer demand, volume declines, delayed inflation recovery, acquisition-related costs, and expected Trivium integration investment remain risks.

Bullish
  • + Full-year 2026 adjusted EPS guidance was raised to $3.83-$3.93, with the midpoint up 4% from $3.72 in 2025.
  • + Record third-quarter adjusted EPS of $1.31 increased 7% and landed at the high end of the estimated range.
  • + Total third-quarter adjusted EBIT increased 6% to $235 million.
  • + High-value dispensing products grew mid-single digits in fragrance and double digits in North American prescription pharma.
  • + Silgan confirmed approximately $450 million of 2026 free cash flow and expects organic earnings and free cash flow growth in 2027.
  • + Fourth-quarter adjusted EPS is guided to $0.76-$0.86, a 21% increase at the midpoint from $0.67 a year earlier.
Bearish
  • − GAAP net income declined to $105.0 million and diluted EPS fell to $0.99 from $1.06.
  • − Metal Containers volume fell 4% because of weaker soup demand, partially offset by growth in fruit and vegetable and pet food.
  • − The proposed Trivium transaction is expected to require incremental investment before its planned mid-2027 close.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Bearish Fundamentals Strong Quant / Vol Moderate
Market backdrop VIX 28.2 · fear Equity put/call 0.89
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +1%
above
Price vs 50-day avg +9%
above
RSI (14) 61
neutral
MACD trend Positive
52-week position 49%
mid-range
Momentum
relative strength
Very Strong
1-month return +16%
trailing
6-month return +14%
trailing
YTD return +3%
this year
Relative strength +15%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $38 › 200d $41 — 200d above 50d
Institutional flow Distributing
151 of 350 funds reported for Sep 30 · net -313.8K sh shares · +27 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
8.79% of shares out · ▲ +3.1% MoM · 8.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
350 holders — mid 3-yr range
Squeeze score 73
high risk · 0–100
Fundamentals
Strong
Revenue growth +1%
Y/Y
Gross margin 26%
expanding
EPS growth +5%
Y/Y
Free cash flow $422.7M
Valuation P/E 16.6
below peers
Buyback $500.0M
remaining
Balance sheet $3.3B
net debt
Quant / Vol
risk profile
Moderate
Volatility 32%
annualized · 1-yr
Max drawdown −29%
past year
ATR 3.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the 8-K filed Oct 29, 2026
full year of 2026
Adjusted net income per diluted share Non-GAAP Raised $3.83 – $3.93
Jul 29, 2026 $3.73 – $3.93 changed to Oct 29, 2026 $3.83 – $3.93
2026
Free cash flow Maintained $450M
Jul 29, 2026 $450M changed to Oct 29, 2026 $450M
Capital expenditures Maintained $310M
Jul 29, 2026 $310M changed to Oct 29, 2026 $310M
fourth quarter of 2026
Adjusted net income per diluted share Non-GAAP $0.76 – $0.86
Previous outlook earlier release · from the Earnings Call filed Jul 29, 2026

Still-open targets the latest release did not restate under the same label.

Corporate expense · full year of 2026 $50M
Interest expense · full year of 2026 $200M
Tax rate · full year of 2026 25% – 26%
Free cash flow · full year of 2026 $450M
CapEx · full year of 2026 $310M
Prior guidance period ended · from the Earnings Call filed Jul 29, 2026
Adjusted EPS · third quarter of 2026 $1.21 – $1.31
Interest expense · third quarter of 2026 $50M – $55M
Adjusted EBIT · third quarter of 2026 $10M
Tax rate · third quarter of 2026 25% – 26%
Guided vs delivered · last 1 settled
Full year earnings guidance full year 2021
guided $3.30 – $3.45
$3.23 Miss −4.3%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+1% Bullish
Price vs 50-day avg
+9% Bullish
RSI (14)
61 Neutral
MACD trend
Positive Bullish
52-week position
49% Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $38 › 200d $41 — 200d above 50d
Institutional flow Distributing
151 of 350 funds reported for Sep 30 · net -313.8K sh shares · +27 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
8.79% of shares out · ▲ +3.1% MoM · 8.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
350 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $35 Now $42 · 49% Range high $49
vs 200-day avg +1% vs 50-day avg +9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBIT - Custom Containers non-GAAP $27.15M Three Months Ended June 30, 2026 filing —
Adjusted EBIT - Dispensing and Specialty Closures non-GAAP $107.6M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Income before interest and income taxes (EBIT) 85.5M
+14.7M Acquired intangible asset amortization expense
+0.3M Other pension expense (income) for U.S. pension plans and closed facilities
+1M Equity in earnings of affiliates, net of tax
+6.1M Rationalization charges
= Adjusted EBIT - Dispensing and Specialty Closures 107.6M
Adjusted EBIT - Metal Containers non-GAAP $65.88M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Income before interest and income taxes (EBIT) 55.4M
+0.4M Acquired intangible asset amortization expense
-1.3M Other pension (income) for U.S. pension plans and closed facilities
+11.4M Rationalization charges
= Adjusted EBIT - Metal Containers 65.9M

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Packaging & Containers — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SLGN
Silgan Holdings Inc
this stock
$4.36B +3.1% +0.9% 16.6 8.8%
SW
Smurfit Westrock plc
 $23.35B +15.1% +47.7% 50.0 4.4%
PKG
Packaging Corp Of America
 $22.22B +20.6% +7.2% 30.7 3.6%
AMCR
Amcor plc
 $21.19B — +56.6% 19.3 5.1%
IP
International Paper Co
 $18.13B -13.1% +49.3% — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
356
% held
92.2%
Reported
151 of 350
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
361
View
Short & Settlement
Short Interest Rising
Shares short
9.3M
Days to cover
8.6d
Change
+280.4K sh
View
Short Volume
Short vol %
45%
As of
Nov 5, 2026
Short Total
View
Fails to Deliver
FTD shares
21
Value
$754
As of
Sep 28, 2026
View
Off-Exchange
Off-exchange %
43.8%
Week of
Sep 28, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Gilbert Cisneros
Amount
$1.0K–$15.0K
Traded
Jan 15, 2026
View
Financials
Financials
Revenue (FY)
$6.5B
Net income (FY)
$288.4M
EPS diluted
$2.70
View
Buybacks
Authorized
$500.0M
Remaining
$500.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 5, 2026
This year
18

Third-quarter net sales rose 1.6 percent to $2.0 billion, but income before interest and income taxes fell to $191.7 million and margin declined to 9.4 percent from 9.9 percent. Total adjusted EBIT increased to $235.0 million from $221.4 million.

View
Proposed Sales
Value
$501.7K
Shares
11.0K
Filed
Aug 20, 2025
View
Earnings & Events
Webcasts
Last webcast
Oct 29, 2026
View
Investor Relations
Latest news
Silgan Declares Quarterly Dividend
Published
Nov 3, 2026
View

Performance

5D 20D 120D MTD YTD
SLGN +5.4% +16.3% +13.7% +2.8% +3.2%
SPY -4.7% -5.3% -0.8% -3.0% +7.5%
vs SPY +10.2% +21.6% +14.5% +5.8% -4.3%

Capital returns

Latest dividend
$0.21 / share · ex Sep 1, 2026
Declared · upcoming
$0.21 / share · ex Dec 1, 2026
Raised 5%
Paid (TTM)
$0.83 / share · 4 payouts
Dividend yield (TTM, derived)
1.99%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$500.00M
Spent (derived)
$0
Remaining
$500.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 849869 CUSIP 827048109 13F (30d) 159 filings 131 filers Visit website Investor relations